Fig. 7From: PI3Kδ inhibition prevents IL33, ILC2s and inflammatory eosinophils in persistent airway inflammationSchematic representation of the key inflammatory pathways involved in allergic pulmonary inflammation and their ablation by PI3Kδ inhibition and anti-IL5 antibody treatmentBack to article page